Invention Grant
- Patent Title: Cell culture substrate comprising a laminin and a cadherin
-
Application No.: US14360040Application Date: 2012-09-19
-
Publication No.: US10240124B2Publication Date: 2019-03-26
- Inventor: Karl Tryggvason , Sergey Rodin
- Applicant: BioLamina AB
- Applicant Address: SE Solna
- Assignee: BioLamina AB
- Current Assignee: BioLamina AB
- Current Assignee Address: SE Solna
- Agency: Fay Sharpe LLP
- International Application: PCT/IB2012/002214 WO 20120919
- International Announcement: WO2013/041961 WO 20130328
- Main IPC: C12N5/074
- IPC: C12N5/074 ; C07K14/705 ; C07K14/78 ; C12M1/12 ; C12N5/00 ; C12N5/0735

Abstract:
The present disclosure related to isolated laminin-521, methods for making recombinant laminin-521, host cells that express recombinant laminin-521, and compositions containing laminin-521. Laminin-521 can maintain stem cells in vitro pluripotency, enable self-renewal, and enable single cell survival of human embryonic stem cells. When pluripotent human embryonic stem cells are cultured on plates coated with recombinant laminin-521 (laminin-11), in the absence of differentiation inhibitors or feeder cells, the embryonic stem cells proliferate and maintain their pluripotency. It has also been discovered that human recombinant laminin-521 (laminin-11) provides single cell survival of stem cells after complete dissociation into a single cell suspension. Useful cell culture mediums containing at most 3.9 ng/ml of beta fibroblast growth factor (bFGF) are also described herein.
Public/Granted literature
- US20140315306A1 CELL CULTURE SUBSTRATE COMPRISING A LAMININ AND A CADHERIN Public/Granted day:2014-10-23
Information query